Manchester Capital Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-17
Closed -$973 1061
2023
Q3
$973 Hold
17
﹤0.01% 838
2023
Q2
$1.01K Sell
17
-110
-87% -$6.58K ﹤0.01% 809
2023
Q1
$7.96K Buy
127
+12
+10% +$749 ﹤0.01% 573
2022
Q4
$7.2K Sell
115
-7
-6% -$401 ﹤0.01% 497
2022
Q3
$6K Buy
122
+17
+16% +$941 ﹤0.01% 499
2022
Q2
$6K Sell
105
-113
-52% -$6.23K ﹤0.01% 543
2022
Q1
$12K Sell
218
-20
-8% -$1.16K ﹤0.01% 521
2021
Q4
$14K Sell
238
-58
-20% -$3.44K ﹤0.01% 523
2021
Q3
$17K Buy
+296
New +$16.3K ﹤0.01% 537

Other funds holding PBH

Manchester Capital Management's PBH Position: Q4 2023 in Review

Manchester Capital Management sold out of Prestige Consumer Healthcare (PBH) in Q4 2023, closing a stake of 17 shares — an estimated $973 sold.

Manchester Capital Management first reported a position in PBH in Q3 2021 and held it in 9 quarters. The position peaked at $17K in Q3 2021. 288 funds tracked by Wall St. Rank hold PBH as of Q4 2023.

  • Manchester Capital Management reported no remaining Prestige Consumer Healthcare position as of Q4 2023 after selling out during the quarter.
  • Manchester Capital Management sold 17 Prestige Consumer Healthcare shares in Q4 2023, an estimated $973.
  • Manchester Capital Management first reported a position in Prestige Consumer Healthcare in Q3 2021 and held it in 9 quarters.
  • Manchester Capital Management's Prestige Consumer Healthcare position peaked at $17K in Q3 2021.
  • 288 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2023.

Based on Manchester Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.